Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab

被引：28

作者：

Colozza, Mariantonietta ^{[1
]}

Minenza, Elisa ^{[1
]}

Gori, Stefania ^{[1
]}

Fenocchio, Daniela ^{[2
]}

Paolucci, Cristina ^{[3
]}

Aristei, Cynthia ^{[4
]}

Floridi, Piero ^{[5
]}

机构：

[1] Azienda Osped, SC Oncol, Perugia, Italy

[2] Azienda Osped, Serv Anat Patol, Perugia, Italy

[3] Azienda Osped, Lab Preparaz Farm Antiblastici, Perugia, Italy

[4] Azienda Osped, Ist Radioterapia, Perugia, Italy

[5] Azienda Osped, SC Neuroradiol, Perugia, Italy

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2009年 / 63卷 / 06期

关键词：

NERVOUS-SYSTEM METASTASES; MENINGEAL CARCINOMATOSIS; THERAPY; PROGRESSION; RISK; PLUS;

D O I：

10.1007/s00280-008-0859-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1157 / 1159

页数：3

共 18 条

[1] Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma [J].

Bendell, JC ;

Domchek, SM ;

Burstein, HJ ;

Harris, L ;

Younger, J ;

Kuter, I ;

Bunnell, C ;

Rue, M ;

Gelman, R ;

Winer, E .

CANCER, 2003, 97 (12) :2972-2977

[2] Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer [J].

Clayton, AJ ;

Danson, S ;

Jolly, S ;

Ryder, WDJ ;

Burt, PA ;

Stewart, AL ;

Wilkinson, PM ;

Welch, RS ;

Magee, B ;

Wilson, G ;

Howell, A ;

Wardley, AM .

BRITISH JOURNAL OF CANCER, 2004, 91 (04) :639-643

[3]

Fouladi M, 2006, J CLIN ONCOL, V24, p517S

[4] Lapatinib plus capecitabine for HER2-positive advanced breast cancer [J].

Geyer, Charles E. ;

Forster, John ;

Lindquist, Deborah ;

Chan, Stephen ;

Romieu, C. Gilles ;

Pienkowski, Tadeusz ;

Jagiello-Gruszfeld, Agnieszka ;

Crown, John ;

Chan, Arlene ;

Kaufman, Bella ;

Skarlos, Dimosthenis ;

Campone, Mario ;

Davidson, Neville ;

Berger, Mark ;

Oliva, Cristina ;

Rubin, Stephen D. ;

Stein, Steven ;

Cameron, David .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26) :2733-2743

[5]

GORI S, 2007, J CLIN ONCOL S, V25, pS54

[6] Clinical utility of continuing trastuzumab beyond brain progression in HER-2-positive metastatic breast cancer -: Reply [J].

Gori, Stefania ;

De Angelis, Verena ;

Colozza, Mariantonietta ;

Crino, Lucio .

ONCOLOGIST, 2007, 12 (12) :1469-1471

[7] Central nervous system metastases in HER-2-positive metastatic breast cancer patients treated with trastuzumab:: Incidence, survival, and risk factors [J].

Gori, Stefania ;

Rimondini, Simonetta ;

De Angelis, Verena ;

Colozza, Mariantonietta ;

Bisagni, Giancarlo ;

Moretti, Gabriella ;

Sidoni, Angelo ;

Basurto, Carlo ;

Aristei, Cynthia ;

Anastasi, Paola ;

Crino, Lucio .

ONCOLOGIST, 2007, 12 (07) :766-773

[8]

Grossi PM, 2003, CLIN CANCER RES, V9, P5514

[9] The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma [J].

Lai, R ;

Dang, CT ;

Malkin, MG ;

Abrey, LE .

CANCER, 2004, 101 (04) :810-816

[10]

Laufman L R, 2001, Clin Breast Cancer, V2, P235

← 1 2 →